Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.
Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B; Cystic Fibrosis Therapeutics Development Network Study Group. Gibson RL, et al. Among authors: rosenfeld m. Am J Respir Crit Care Med. 2003 Mar 15;167(6):841-9. doi: 10.1164/rccm.200208-855OC. Epub 2002 Dec 12. Am J Respir Crit Care Med. 2003. PMID: 12480612 Clinical Trial.
Cystic fibrosis pulmonary exacerbations.
Ferkol T, Rosenfeld M, Milla CE. Ferkol T, et al. Among authors: rosenfeld m. J Pediatr. 2006 Feb;148(2):259-64. doi: 10.1016/j.jpeds.2005.10.019. J Pediatr. 2006. PMID: 16492439 Review. No abstract available.
Endpoints for clinical trials in young children with cystic fibrosis.
Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M. Davis SD, et al. Among authors: rosenfeld m. Proc Am Thorac Soc. 2007 Aug 1;4(4):418-30. doi: 10.1513/pats.200703-041BR. Proc Am Thorac Soc. 2007. PMID: 17652509 Free PMC article. Review.
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.
Treggiari MM, Rosenfeld M, Mayer-Hamblett N, Retsch-Bogart G, Gibson RL, Williams J, Emerson J, Kronmal RA, Ramsey BW; EPIC Study Group. Treggiari MM, et al. Among authors: rosenfeld m. Contemp Clin Trials. 2009 May;30(3):256-68. doi: 10.1016/j.cct.2009.01.003. Epub 2009 Jan 15. Contemp Clin Trials. 2009. PMID: 19470318 Free PMC article. Clinical Trial.
Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
Cystic Fibrosis Foundation; Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation, et al. Among authors: rosenfeld m. J Pediatr. 2009 Dec;155(6 Suppl):S106-16. doi: 10.1016/j.jpeds.2009.09.003. J Pediatr. 2009. PMID: 19914443 Free PMC article.
Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.
Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, Mogayzel PJ, Johnson RC, Wilcox SL, Castile RG. Davis SD, et al. Among authors: rosenfeld m. Am J Respir Crit Care Med. 2010 Dec 1;182(11):1387-97. doi: 10.1164/rccm.200908-1236OC. Epub 2010 Jul 9. Am J Respir Crit Care Med. 2010. PMID: 20622043 Free PMC article.
1,294 results